119 related articles for article (PubMed ID: 8957447)
1. Classification of astrocytomas and malignant astrocytomas by principal components analysis and a neural net.
McKeown MJ; Ramsay DA
J Neuropathol Exp Neurol; 1996 Dec; 55(12):1238-45. PubMed ID: 8957447
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted discrimination of glioblastomas.
Scarpelli M; Montironi R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
[TBL] [Abstract][Full Text] [Related]
3. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
4. [Grading of astrocytomas and oligodendrogliomas].
Kolles H; Niedermayer I; Feiden W
Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
[TBL] [Abstract][Full Text] [Related]
5. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.
Hang JF; Hsu CY; Lin SC; Wu CC; Lee HJ; Ho DM
Mod Pathol; 2017 Mar; 30(3):318-328. PubMed ID: 27910945
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
7. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.
Sallinen PK; Sallinen SL; Helén PT; Rantala IS; Rautiainen E; Helin HJ; Kalimo H; Haapasalo HK
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):319-31. PubMed ID: 10931365
[TBL] [Abstract][Full Text] [Related]
8. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
9. [Computer assisted grading of gliomas of the astrocytoma/glioblastoma groups].
Kolles H; von Wangenheim A; Niedermayer I; Vince GH; Feiden W
Verh Dtsch Ges Pathol; 1994; 78():427-31. PubMed ID: 7534014
[TBL] [Abstract][Full Text] [Related]
10. [Gemistocytic astrocytomas].
Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
[TBL] [Abstract][Full Text] [Related]
11. A dual neural network ensemble approach for multiclass brain tumor classification.
Sachdeva J; Kumar V; Gupta I; Khandelwal N; Ahuja CK
Int J Numer Method Biomed Eng; 2012 Nov; 28(11):1107-20. PubMed ID: 23109381
[TBL] [Abstract][Full Text] [Related]
12. Nomenclature for gliomas.
Vogel FS
Natl Cancer Inst Monogr; 1977 Dec; 46():51-6. PubMed ID: 206838
[TBL] [Abstract][Full Text] [Related]
13. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
Fulling KH; Nelson JS
Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.
Senetta R; Mellai M; Manini C; Castellano I; Bertero L; Pittaro A; Schiffer D; Boldorini R; Cassoni P
Histopathology; 2016 Aug; 69(2):329-37. PubMed ID: 26845757
[TBL] [Abstract][Full Text] [Related]
15. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
Krafft C; Thümmler K; Sobottka SB; Schackert G; Salzer R
Biopolymers; 2006 Jul; 82(4):301-5. PubMed ID: 16506167
[TBL] [Abstract][Full Text] [Related]
16. Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.
Decaestecker C; Camby I; Nagy N; Brotchi J; Kiss R; Salmon I
Brain Pathol; 1998 Jan; 8(1):29-38. PubMed ID: 9458164
[TBL] [Abstract][Full Text] [Related]
17. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
18. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
Nafe R; Van de Nes J; Yan B; Schlote W
Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
[TBL] [Abstract][Full Text] [Related]
19. Dual lineage of astrocytomas.
Bishop M; de la Monte SM
Am J Pathol; 1989 Sep; 135(3):517-27. PubMed ID: 2551172
[TBL] [Abstract][Full Text] [Related]
20. Grading astrocytomas.
Adelman LS
Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
